Beijing: One of the leading vaccines in the world made by China’s Sinopharm has reportedly been administered to lakhs of people.
The vaccine comes in two-doses and it is reported that none of the recipients developed an adverse reaction or infection.
The vaccine has been administered under an emergency-use programme and is being tested on frontline workers. Pregnant and breast-feeding women are not being given the vaccine.
The state-run company has invested over 2 billion USD for the vaccine and is currently carrying Phase 3 testing in the Middle-East and South Africa, apart from China. The vaccine is based on an inactive coronavirus. The Oxford vaccine, which recently hit a roadblock after a volunteer develops an unexplained illness, is based on Chimpanzee adenovirus.
Sinopharm’s vaccine is expected to hit the market by the end of the year if everything goes right.
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
Balasore: With the festival of Maha Shivratri fast approaching, hectic preparations are underway at the… Read More
New Delhi: In a recent social media post, actress Kangana Ranaut sparked controversy by defending… Read More
This website uses cookies.
